S

Sonic Healthcare USA

Laboratory and pathology testing services

Histology Laboratory Supervisor

Full-Time
$90k - $130k/yr
Senior
Bachelor's, Associate's
White Plains, NY, USA
In Person
Medical, Clinical & VeterinaryDiagnostics & Laboratory Professionals

About the job

Requirements
  • Possesses an Associate degree in Histology, Biology, Chemistry or another related field; the degree must satisfy the Clinical Laboratory Improvement Amendments standards for grossing surgical specimens, including 12 combined course hours of Biology and Chemistry.
  • Has 5 or more years of experience in the histology field.
  • Holds and maintains the Histotechnician or Histotechnologist certification from the American Society for Clinical Pathology.
  • May substitute additional education and/or experience for certification when certification is not a jurisdictional requirement.
  • Has strong interpersonal, verbal, and written communication skills.
  • Can work independently and in a team environment.
  • Is detail-oriented and demonstrates high integrity and discipline.
  • Has time-management skills to prioritize work and meet deadlines.
  • Has basic computer competency.
Responsibilities
  • Performs supervisory tasks including hiring, training, coaching, scheduling, directing, and appraising the work of assigned staff.
  • Performs the work of supervised staff as a working supervisor.
  • Manages direct reports.
  • Holds monthly one-on-one meetings with direct reports.
  • Advocates for direct reports by ensuring their ideas are heard and supporting their career progression planning and efforts.
  • Maintains accurate records.
  • Adheres to laboratory quality-control policies, documents quality-control activities, and maintains a clean and well-organized work area.
  • Maintains proficiency and training requirements.
  • Ensures compliance with local, federal, and Clinical Laboratory Improvement Amendments regulations.
  • Participates in inventory management and special projects.
  • Assists with staff development and training.
  • Assists the Lab Manager with maintaining Clinical Laboratory Improvement Amendments documentation and records, including supervising and verifying completion of daily records and tracking documents, and preparing for College of American Pathologists and New York State/Clinical Laboratory Improvement Amendments inspections.
  • Communicates with pathologists regarding laboratory issues and client needs, and responds to concerns and feedback regarding histology within the laboratory.
  • Tracks and monitors laboratory quality indicators.
  • Answers technical questions from pathologists and clients regarding laboratory processes and histology workflows.
  • Independently identifies laboratory problems and institutes appropriate corrective actions.
  • Ensures operational compliance with laboratory standard operating procedures and Quality Management Systems.
  • Exercises laboratory safety precautions and adheres to laboratory procedures in procedure manuals.
Desired Qualifications
  • A Bachelor's degree is preferred.

About the company

Sonic Healthcare USA provides laboratory testing and professional pathology services across the United States as part of Sonic Healthcare Limited, one of the world’s largest medical diagnostics groups. It operates through nine divisions and around eight thousand employees, following a federated model that puts medical leadership at the local level to ensure high-quality, community-based testing for doctors and patients. Its tests cover core diagnostic laboratory services and pathology expertise used by medical practitioners, hospitals, and community health services. The company aims to deliver precise, timely results and strong clinical partnerships to improve patient care by offering comprehensive laboratory testing and pathology support while maintaining close ties to local healthcare providers.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Austin, Texas

Founded

2014

Get referred to Sonic Healthcare USA

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BCAL and Sonic advanced BreastestPlus validation in Austin on 2026-05-28.
  • Cairo Diagnostics expands oncology testing nationwide and supports liquid biopsy ambitions.
  • FY2026 U.S. underlying organic growth reached 2% after Alabama and AP restructuring.

What critics are saying

  • Veracyte's patent case against Sonic Healthcare USA remains active in Texas federal court.
  • The 2025 Alabama payer loss and nine-practice AP rationalization prove reimbursement fragility.
  • Jan. 1, 2027 PAMA cuts and Change Healthcare debtor write-downs pressure margins.

What makes Sonic Healthcare USA unique

  • Federated model gives local pathologists decision authority inside a national U.S. network.
  • CLIA labs in Austin, Dallas, and New York support rapid LDT validation.
  • Acquired Cairo Diagnostics on 2025-08-22, adding integrated hematology-oncology reporting.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • 401(k) Retirement Plan
  • 401(k) Company Match

Company News

Daily Dispatch
May 28th, 2026
BCAL Diagnostics and Sonic Healthcare advance validation of BreastestPlus Version 2 for US market.

BCAL Diagnostics and Sonic Healthcare advance validation of BreastestPlus Version 2 for US market. BCAL Diagnostics (ASX:BDX) has taken a step toward bringing its flagship blood test to the United States by signing a Validation Agreement with Sonic Healthcare USA. The agreement calls for BreastestPlus Version 2 to be transferred to Sonic's CLIA-certified Sonic Reference Laboratory in Austin, Texas, where the assay will be optimised and validated for the US market. The move follows BCAL's aim to establish BreastestPlus Version 2 as a Laboratory Developed Test in the US, a pathway the company describes as the fastest and most efficient route for US market entry. The US breast cancer diagnostics market is large and growing, with more than 40 million mammograms performed annually and roughly 376,000 new breast cancer cases each year. BCAL said successful validation at Sonic's facility would represent a key milestone on that pathway and could lead to commercial licensing discussions between the two organisations. BCAL said it also continues to collect clinical samples from patients across the US in collaboration with leading breast cancer specialists. Those samples will support BCAL's Clinical Outcomes studies, which the company says are necessary for regulatory and reimbursement submissions. Shane Ryan, Chief Executive Officer, BCAL, said, "This Validation Agreement with Sonic Healthcare USA is an important milestone for BCAL Diagnostics and our US commercialisation strategy. Sonic's CLIA-certified laboratory infrastructure and deep expertise in clinical diagnostics provide the right environment to validate BreastestPlus(TM) Version 2. What excites me most is what this brings together - two highly capable teams, united by a shared purpose of delivering better diagnostic solutions for women at scale. We look forward to progressing through the validation process and advancing towards commercial deployment in the world's largest breast cancer diagnostics market." Dr Mohamed Salama, Chief Medical Officer, Sonic Healthcare USA, said, "Sonic Healthcare USA is committed to advancing access to innovative diagnostic solutions that make a real difference to patients. The validation of BreastestPlus(TM) Version 2 at our CLIA-certified Sonic Reference Laboratory in Austin, Texas, reflects that commitment, and we look forward to assessing its performance through a rigorous validation process." The financial terms of the Validation Agreement were not disclosed.

Newswise
Aug 22nd, 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities

Sonic Healthcare USA, Inc. announces acquisition of Cairo Diagnostics LLC to expand Sonic's national hematology oncology testing capabilities.

PR Newswire
Aug 22nd, 2025
Sonic Healthcare Acquires Cairo Diagnostics

Sonic Healthcare USA, Inc. has acquired Cairo Diagnostics LLC to enhance its national hematology oncology testing capabilities. Founded by Dr. Sherif Ibrahim, Cairo is known for its integrated oncology testing approach, combining various diagnostic methods to provide comprehensive reports. This acquisition aims to expand Sonic's reach and improve service to oncologists nationwide, offering faster and more complete diagnostic solutions.

The West Australian
Mar 20th, 2024
Sonic Healthcare beefs up Swiss presence with $202m purchase of laboratory group Dr Risch

Sonic Healthcare will beef up its presence in Switzerland with the purchase of laboratory group Dr Risch for 117 million Swiss francs ($202m).

Business News Australia
Apr 27th, 2023
Sonic announces $611m in German acquisitions in April

Australias largest pathology company has today announced its second German acquisition this month, with binding agreements signed to purchase Medical Laboratori